What Maxx Orthopedics does

Maxx Orthopedics (formerly Maxx Medical) is a US-based, founder-led orthopedic medical device company founded in 2007 and headquartered in Norristown, Pennsylvania. It develops, manufactures, and markets large-joint reconstructive implants — primarily total and partial knee arthroplasty and total hip arthroplasty systems — sold under the Freedom Knee, Libertas Hip, and Titan sub-brands. The portfolio spans unicondylar/resurfacing, primary, complex primary, and revision knee systems, plus a hip portfolio covering cemented, uncemented, HA-coated, bipolar, and short metaphyseal stems, supported by acetabular cups and ceramic/CoCr head options from partner CeramTec.

The company's underlying technology stack combines patented Progressive Constraint Kinematics (PCK) with a trapezoidal femoral box, additive-manufactured porous Ti6Al4V tibial baseplates and metaphyseal cones, a proprietary Titanium Niobium Nitride (TiNbN) coating addressing metal sensitivity, Ti-GrowthC plasma spray coatings for biologic fixation, and an IDE-stage PEEK-OPTIMA polymer femoral component co-developed with Invibio. Beyond implants, the Quick Recovery Solutions (QRS) platform bundles a single-tray instrument set (QRS One Tray), cloud-hosted templating software (QRS Sizer), and, since the February 2026 acquisition of TracPatch, wearable post-operative recovery monitoring — positioning Maxx as an outpatient-episode solution for ambulatory surgery centers.

The business model is hardware sales of sterile-packaged implants and instrument trays sold directly to hospitals and ASCs in the US and through regional distributors across Latin America, Asia (India manufacturing, Singapore commercial), and Europe (64+ countries); 1,470+ surgeon partners and 490k+ cumulative patients indicate an installed base that supports incremental product cross-sell. Pricing is contract-negotiated and not publicly disclosed, and the company remains privately held with no disclosed institutional investor, capital raise, or revenue figure in the source material.

Name

Maxx Orthopedics

Legal name

Maxx Orthopedics, Inc.

Website

https://maxxortho.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

Maxx Orthopedics is a privately held orthopedic device company that develops and markets knee and hip implant systems (Freedom Knee, Libertas Hip) plus the QRS outpatient surgical platform, selling directly to hospitals and ambulatory surgery centers across 64+ countries.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Orthopedic implants
• Knee replacement systems
• Hip replacement solutions
• Outpatient arthroplasty
• Medical device manufacturing

Headquarters

HQ city

Norristown

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Orthopedic Implant Sales: Maxx Orthopedics generates revenue primarily through the sale of orthopedic knee and hip implant systems including Freedom Knee Solutions, Libertas Hip Solutions, and associated instrumentation. Revenue is generated from one-time device sales to hospitals, surgery centers, and surgeons.
2. Quick Recovery Solutions (QRS) Platform: Following the acquisition of TracPatch, Maxx Orthopedics offers an integrated outpatient surgical platform including instrument trays (QRS One Tray), cloud-hosted templating software (QRS Sizer), and wearable patient monitoring technology, creating recurring engagement across the surgical episode.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Maxx Orthopedics develops, manufactures, and markets orthopedic joint replacement implant systems for knee and hip arthroplasty, sold primarily to hospitals and ambulatory surgery centers. The core portfolio includes Freedom Knee Solutions (partial, primary, and revision knee systems), Libertas Hip Solutions (stems, cups, liners, and bipolar heads), and the Quick Recovery Solutions (QRS) outpatient surgery platform integrating instrument trays, cloud-based templating software, and wearable patient monitoring technology acquired through TracPatch. Products are sold globally through direct enterprise sales in the US and regional distributors across 60+ international markets.

Product overview

Maxx Orthopedics is a medical device company offering three integrated product lines: Freedom Knee Solutions (partial, primary, and revision knee systems including Porous, PCK, and Titan variants with TiNbN coating), Libertas Hip Solutions (comprehensive hip portfolio with stems, cups, and bipolar options in multiple fixation strategies), and Quick Recovery Solutions (QRS) platform for outpatient surgery centers. The portfolio spans from outpatient partial knee resurfacing to complex revision procedures, with recent expansion through the acquisition of TracPatch wearable sensor technology for integrated patient recovery monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• Freedom Knee Solutions: Knee implant systems including partial, primary, and revision knee solutions. Products include Freedom Partial Knee, Freedom Renew Knee, Freedom Primary Knee, Freedom Porous Knee, Freedom Primary PCK, Freedom PCK Revision Knee, and Freedom Titan Knee.
• Libertas Hip Solutions
• Quick Recovery Solutions (QRS)

Products and services

• Freedom Partial Knee System

Quantifiable outcome

• 98.3% implant survivorship rate at 10 years for Freedom Total Knee System
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Orchid (contract manufacturer)coreImplementation/ SI/ Consulting Partner · 28 July 2025Orchid provided electron beam melting (EBM) capabilities and end-to-end supply chain services for Maxx Orthopedics' cementless Porous Tibial Baseplate, developed using additive manufacturing technology. The partnership replaced a prior supplier that lacked necessary regulatory expertise, resulting in significantly reduced production times and validated cleaning processes to ensure device safety. This collaboration was critical for achieving FDA 510(k) clearance of the porous tibial baseplate in February 2025.
• Invibio Biomaterial Solutions (Victrex plc)coreStrategic or Co-development Partner · 17 September 2024Maxx Orthopedics partnered with Invibio to develop and secure FDA IDE approval for a PEEK-OPTIMA polymer femoral component for the Freedom Total Knee System. Invibio is involved in component development, knee performance testing, optimization, and manufacturing using the polymer. The partnership represents over a decade of collaboration, with the PEEK-OPTIMA femoral component designed to offer modulus close to cortical bone and radiolucent imaging properties. First US cases were performed in June 2025.
• CeramTec (BIOLOX delta ceramic)minorOEM/ Whitelabel/ Licensing PartnerCeramTec supplies the BIOLOX delta ceramic femoral heads used in Maxx Orthopedics' Libertas Hip Solutions. The ceramic heads feature a polished articulating surface and are offered as an option alongside polished cobalt chrome heads for hip replacement procedures.
• TracPatch (acquired from Granger Capital, LLC)coreOthersMaxx Orthopedics acquired TracPatch wearable sensor technology from Granger Capital, LLC in February 2026. TracPatch provides real-time patient recovery monitoring through wearable sensors, tracking key recovery metrics post-surgery. The acquisition integrates TracPatch into Maxx's QRS platform, expanding it into a fully integrated recovery ecosystem for outpatient total joint replacement. Granger Capital was the financial owner of TracPatch prior to the acquisition.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Stryker: Global orthopedic leader with the Mako robotic-assisted surgery platform and comprehensive hip and knee reconstruction portfolios. Directly competes with Maxx Orthopedics across primary and revision joint replacement, but at vastly larger scale with integrated robotics.
• Smith & Nephew: Multinational medical device company with a major orthopedics franchise including Journey II and Legion knee systems and the CORI handheld robotic system. Direct competitor to Maxx in knee and hip reconstruction globally.
• Zimmer Biomet: One of the largest pure-play orthopedic device companies, offering Persona Knee, Oxford Partial Knee, and ROSA Robotics, plus comprehensive hip systems. Direct competitor to Maxx in joint reconstruction across all major markets.
• DePuy Synthes (Johnson & Johnson): J&J's orthopedic arm offering the Attune Knee System and a broad hip portfolio, including robotic-assisted solutions. Directly competes with Maxx Orthopedics in the same hospital and ASC channels.

Direct peers

• Exactech: Mid-sized US-based orthopedic device company specializing in knee and hip implants, including Truliant and Vantage systems. Highly comparable to Maxx in scale, product portfolio, and target market of joint reconstruction surgeons and ASCs.
• Enovis (DJO Surgical): Mid-sized orthopedic company offering the EMPOWR Knee and hip reconstruction systems with a strong ASC channel focus. Direct competitor to Maxx Orthopedics in primary and revision joint replacement.
• Waldemar Link: German-based mid-market orthopedic company with established knee (Gemini SL) and hip systems, plus a strong revision knee franchise. Comparable to Maxx as a privately held, focused orthopedic specialist with global distribution.
• Corin Group: UK-based orthopedic company focused on hip and knee implants with connected technologies for outcome monitoring. Similar mid-tier scale and joint reconstruction focus to Maxx Orthopedics.

Regional players

• MicroPort Orthopedics: Orthopedic subsidiary of MicroPort Scientific with the Evolution Knee and hip systems, primarily strong in Asia and emerging markets with growing US presence. Comparable product portfolio to Maxx with overlapping distribution geographies.
• Amplitude Surgical: French orthopedic company with knee (Anatomical and Score) and hip reconstruction systems. Comparable mid-tier player to Maxx in joint replacement with primary strength in European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/MaxxOrthopedics
• YouTubeyoutube.com/channel/UCd8GUB8eWzT3pJlRqLCmL6w
• Facebookfacebook.com/MaxxOrthopedics
• LinkedInlinkedin.com/company/maxxorthopedics
• Instagraminstagram.com/maxxorthopedics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maxx Orthopedics